Swedbank AB Purchases 47,541 Shares of Cigna Group $CI

Key Points

• Swedbank AB increased its stake in Cigna Group by 7.7% in Q4, buying 47,541 shares to hold 662,728 shares (about 0.25% of the company) valued at roughly $182.4 million per its SEC filing.
• Cigna beat estimates with Q EPS of $7.79 (vs. $7.60) and revenue of $68.52 billion, provided FY2026 EPS guidance of about 30.35, and declared a quarterly dividend of $1.56 ($6.24 annualized, ~2.3% yield).

Swedbank AB raised its position in Cigna Group (NYSE:CI - Free Report) by 7.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 662,728 shares of the health services provider's stock after buying an additional 47,541 shares during the period. Swedbank AB owned 0.25% of Cigna Group worth $182,403,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Brighton Jones LLC increased its stake in shares of Cigna Group by 9.3% in the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider's stock valued at $1,032,000 after buying an additional 318 shares in the last quarter. Sivia Capital Partners LLC grew its holdings in Cigna Group by 10.4% during the 2nd quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider's stock worth $384,000 after acquiring an additional 109 shares during the last quarter. NewEdge Advisors LLC raised its stake in shares of Cigna Group by 4.5% in the second quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider's stock worth $7,347,000 after acquiring an additional 958 shares during the last quarter. Treasurer of the State of North Carolina lifted its position in shares of Cigna Group by 16.6% during the second quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider's stock worth $49,204,000 after purchasing an additional 21,173 shares in the last quarter. Finally, Osterweis Capital Management Inc. acquired a new stake in shares of Cigna Group in the second quarter valued at approximately $163,000. Institutional investors and hedge funds own 86.99% of the company's stock.

Cigna Group Stock Performance

Shares of Cigna Group stock opened at $275.73 on Wednesday. The stock's fifty day simple moving average is $274.24 and its 200 day simple moving average is $276.50. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. The company has a market capitalization of $72.94 billion, a PE ratio of 11.69, a PEG ratio of 0.98 and a beta of 0.30. Cigna Group has a 12 month low of $239.51 and a 12 month high of $338.89.

Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The company had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. During the same period in the prior year, the company earned $6.74 earnings per share. The company's revenue for the quarter was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, research analysts predict that Cigna Group will post 30.4 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be issued a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. The ex-dividend date is Thursday, June 4th. Cigna Group's dividend payout ratio is 26.45%.

Analyst Ratings Changes

A number of research analysts have commented on CI shares. Robert W. Baird set a $337.00 price objective on Cigna Group in a research report on Friday. Truist Financial raised their price target on Cigna Group from $320.00 to $350.00 and gave the company a "buy" rating in a report on Tuesday, February 17th. Jefferies Financial Group dropped their price objective on Cigna Group from $333.00 to $330.00 and set a "buy" rating for the company in a report on Monday, April 20th. Royal Bank Of Canada lifted their price target on shares of Cigna Group from $333.00 to $337.00 and gave the stock an "outperform" rating in a research report on Friday, May 1st. Finally, UBS Group restated a "buy" rating and issued a $375.00 price objective on shares of Cigna Group in a report on Monday, February 9th. One analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $338.35.

Insider Activity at Cigna Group

In other news, insider Nicole S. Jones sold 2,307 shares of the stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the sale, the insider owned 32,647 shares of the company's stock, valued at $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Everett Neville sold 1,719 shares of the firm's stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the sale, the insider owned 5,670 shares in the company, valued at approximately $1,638,119.70. The trade was a 23.26% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.60% of the stock is owned by corporate insiders.

About Cigna Group

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.